No Data
No Data
Eli Lilly and Co (LLY.US) explores new uses for "miracle weight-loss drug" Zepbound, aiming to reduce the incidence of diabetes and other high-risk populations.
eli lilly and co is exploring new uses for its weight loss drug Zepbound to reduce the incidence of diabetes in high-risk populations, even if they are not overweight.
US HHS Reveal Cost Savings For 54 Prescription Drugs Including Novartis' Cancer Drug, Ozempic Could Be Next
Sector Update: Health Care Stocks Retreat Tuesday Afternoon
Port Strike Fallout: Blockbuster Weight-loss Drug Supply From Wegovy to Ozempic, Mounjaro, Zepbound Caught up in East Coast Trade Shutdown
Eli Lilly's Options: A Look at What the Big Money Is Thinking
Lilly Looking to Test Zepbound as Health Maintenance Drug: Report